LivaNova PLC Payments for (Proceeds from) Derivative Instrument, Financing Activities
LivaNova PLC (LIVN) reported Payments for (Proceeds from) Derivative Instrument, Financing Activities of $390.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities · last filed 2018-08-02
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2018-06-30 was -$4.42M.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2018-03-31 was $4.81M, a 164.38% increase year-over-year.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2017-12-31 was $1.82M, a 5.15% increase year-over-year.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2017-09-30 was $3.46M.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for fiscal 2017 was $5.37M, a 934.30% increase from fiscal 2016.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for fiscal 2016 was $519.00K.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for fiscal 2015 was -$3.58M.
- LivaNova PLC payments for (proceeds from) derivative instrument, financing activities for fiscal 2014 was $0.00.
| Period end | Payments for (Proceeds from) Derivative Instrument, Financing Activities 3 month | Payments for (Proceeds from) Derivative Instrument, Financing Activities 3 month as first filed | Payments for (Proceeds from) Derivative Instrument, Financing Activities 6 month | Payments for (Proceeds from) Derivative Instrument, Financing Activities 6 month as first filed | Payments for (Proceeds from) Derivative Instrument, Financing Activities 8 month | Payments for (Proceeds from) Derivative Instrument, Financing Activities 9 month | Payments for (Proceeds from) Derivative Instrument, Financing Activities 12 month | Payments for (Proceeds from) Derivative Instrument, Financing Activities 12 month as first filed | Payments for (Proceeds from) Derivative Instrument, Financing Activities 20 month |
|---|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $390.00K 10-Q · filed 2018-08-02 | $2.21M derived: sum of 3 quarters · filed 2018-08-02 | $5.66M derived: sum of 4 quarters · filed 2018-08-02 | |||||
| 2018-03-31 | $4.81M 10-Q · filed 2018-05-03 | $6.63M derived: sum of 2 quarters · filed 2018-05-03 | $10.08M derived: sum of 3 quarters · filed 2018-05-03 | $8.36M derived: sum of 4 quarters · filed 2018-08-02 | |||||
| 2017-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $5.27M derived: sum of 2 quarters · filed 2018-02-28 | $3.55M derived: sum of 3 quarters · filed 2018-08-02 | $5.37M 10-K · filed 2018-02-28 | |||||
| 2017-09-30 | $3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.73M derived: sum of 2 quarters · filed 2018-08-02 | $3.55M 10-Q · filed 2017-11-02 | $5.28M derived: sum of 4 quarters · filed 2018-08-02 | |||||
| 2017-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $97.00K 10-Q · filed 2018-08-02 | $1.69M 10-Q · filed 2017-08-09 | $1.82M derived: sum of 3 quarters · filed 2018-08-02 | $1.78M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $1.82M 10-Q · filed 2018-05-03 | $3.55M derived: sum of 2 quarters · filed 2018-05-03 | $3.51M derived: sum of 3 quarters · filed 2018-05-03 | $1.99M derived: sum of 4 quarters · filed 2018-05-03 | |||||
| 2016-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.69M derived: sum of 2 quarters · filed 2018-02-28 | $173.00K derived: sum of 3 quarters · filed 2018-02-28 | $519.00K 10-K · filed 2018-02-28 | -$145.00K 10-K · filed 2017-03-01 | ||||
| 2016-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$1.55M derived: sum of 2 quarters · filed 2017-11-02 | -$1.21M 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.17M 10-Q · filed 2017-08-09 | -$299.00K 10-Q · filed 2016-08-05 | ||||||
| 2016-03-31 | $346.00K 10-Q · filed 2017-05-03 | $482.00K 10-Q · filed 2016-05-09 | |||||||
| 2015-12-31 | -$1.26M 10-K · filed 2017-03-01 | -$3.60M 10-K · filed 2018-02-28 | |||||||
| 2015-07-24 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $0.00 10-Q · filed 2016-08-05 | |||||||
| 2015-04-24 | $0.00 10-Q · filed 2016-05-09 | -$3.58M 10-K · filed 2018-02-28 | $0.00 10-KT · filed 2016-03-04 | ||||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 | ||||||||
| 2013-04-26 | $0.00 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |